|
|
|
|
|
|
Companies > Preclinical
|
|
|
Aeromics will develop new small molecule therapeutics, exploiting a novel target for the treatment of CNS edema. The company will exploit the founders’ expertise in the biological control of water and gas permeation in pathological and normal tissues.
Funders:
Grants
|
|
|
|
|